Search

Cloetta AB

Slēgts

35.52 -0.28

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

34.84

Max

35.54

Galvenie mērījumi

By Trading Economics

Ienākumi

-88M

116M

Pārdošana

39M

2.1B

P/E

Sektora vidējais

15.836

27.54

EPS

0.27

Dividenžu ienesīgums

3.03

Peļņas marža

5.582

Darbinieki

2,553

EBITDA

-185M

177M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

3.03%

3.88%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

761M

10B

Iepriekšējā atvēršanas cena

35.8

Iepriekšējā slēgšanas cena

35.52

Cloetta AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 31. okt. 17:40 UTC

Iegādes, apvienošanās, pārņemšana

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

2025. g. 1. nov. 12:56 UTC

Peļņas

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

2025. g. 1. nov. 12:56 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2025. g. 1. nov. 12:20 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2025. g. 1. nov. 12:19 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2025. g. 1. nov. 08:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 1. nov. 08:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 1. nov. 00:10 UTC

Peļņas

Trouble on The Strip -- Barrons.com

2025. g. 31. okt. 23:09 UTC

Peļņas

Review & Preview: October Surprise -- Barrons.com

2025. g. 31. okt. 22:44 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

2025. g. 31. okt. 21:25 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

2025. g. 31. okt. 21:20 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

2025. g. 31. okt. 21:12 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

2025. g. 31. okt. 21:12 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

2025. g. 31. okt. 21:12 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

2025. g. 31. okt. 20:51 UTC

Iegādes, apvienošanās, pārņemšana

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

2025. g. 31. okt. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 31. okt. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 31. okt. 20:50 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 31. okt. 20:46 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

2025. g. 31. okt. 20:22 UTC

Peļņas

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

2025. g. 31. okt. 20:02 UTC

Peļņas

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

2025. g. 31. okt. 19:55 UTC

Tirgus saruna

Crude Futures Fall for Third Straight Month -- Market Talk

2025. g. 31. okt. 19:54 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

2025. g. 31. okt. 19:54 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

2025. g. 31. okt. 19:26 UTC

Tirgus saruna

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

2025. g. 31. okt. 18:30 UTC

Peļņas

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

2025. g. 31. okt. 18:23 UTC

Tirgus saruna

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

2025. g. 31. okt. 18:09 UTC

Peļņas

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

2025. g. 31. okt. 18:08 UTC

Peļņas

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Cloetta AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Cloetta AB

Cloetta AB (publ) operates as a confectionary company. It operates through Branded Packaged Products and Pick & Mix segments. The company manufactures and markets chocolate confectionery products, including pralines, chocolate wafers, dragees, plates, and countlines under the Kexchoklad, Polly, Plopp, Tupla, Royal, Sportlunch, Bridge, Lonka, Sinas, and Snippers brands. It also provides confectionery products comprising foams, wine gums, liquorice, toffees, hard boiled candies, and lollypops under the Malaco, Red Band, Ahlgrens bilar, Venco, Chewits, and Juleskum brands. In addition, the company offers pastilles under the Läkerol, Mynthon, and King brands, as well as chewing gums under the Jenkki, Sportlife, and Xylifresh brands. Further, it produces and sells dry roasted nuts under the Nutisal brand. The company sells its products through a network of grocery retail trade, service trade, e-commerce, and other sales channels in Sweden, Finland, the Netherlands, Denmark, Norway, Germany, the United Kingdom, and internationally. Cloetta AB (publ) was founded in 1862 and is headquartered in Sundbyberg, Sweden.
help-icon Live chat